News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2023-11-08 11:19:28 am Akebia Therapeutics, Inc. (AKBA) Q3 2023 Earnings Call Transcript SeekingAlpha
2023-11-08 4:40:51 am Akebia Therapeutics: Q3 Earnings Snapshot Associated Press Finance
2023-11-08 4:30:0 am Akebia Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights PR Newswire
2023-11-02 1:30:0 pm Akebia Therapeutics Announces Favorable Payment Term Modification of Loan Agreement with Pharmakon Advisors PR Newswire
2023-11-01 1:5:0 pm Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire
2023-10-31 5:0:0 am Akebia Therapeutics to Report Third Quarter 2023 Financial Results and Discuss Recent Business Highlights PR Newswire
2023-10-26 7:2:8 am Akebia Therapeutics (AKBA) May Report Negative Earnings: Know the Trend Ahead of Q3 Release Zacks
2023-10-25 5:30:0 am Akebia Receives FDA Acceptance of Resubmission to NDA of Vadadustat for the Treatment of Anemia due to Chronic Kidney Disease PR Newswire
2023-10-18 5:0:0 am Akebia Therapeutics Announces Five Poster Presentations at ASN Kidney Week 2023 PR Newswire
   

Please consider a small donation if you think this website provides you with relevant information